State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,017,072 shares of Twist Bioscience Corp common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: State Street Corporation reported beneficial ownership of 3,017,072 shares of Twist Bioscience Corp common stock.
  • Percent of class: The reported stake represents 4.6% of the outstanding class of common stock.
  • Shared voting power: State Street disclosed shared voting power over 2,846,126 shares, with zero sole voting power.
  • Shared dispositive power: The filing reports shared dispositive power over 3,017,072 shares, with zero sole dispositive power.
  • Filing event date: The date of the event requiring the filing was September 30, 2026.
  • Subsidiaries involved: Five investment adviser subsidiaries are identified as having acquired the securities, including SSGA Funds Management, Inc. and State Street Global Advisors Europe Limited, among others.

State Street's Schedule 13G Filing on Twist Bioscience Common Stock

State Street Corporation, a holding company organized in Massachusetts and headquartered at One Congress Street, Suite 1, Boston, MA 02114, filed a Schedule 13G disclosing a position in Twist Bioscience Corp (CUSIP 90184D100), whose principal executive offices are located at 681 Gateway Boulevard, San Francisco, California, 94158. According to the filing, the event triggering the disclosure occurred on September 30, 2026, and the statement was signed by Alok Maheshwary, Senior Vice President, on November 9, 2026.

The filing reports aggregate beneficial ownership of 3,017,072 shares, representing 4.6% of the class of common stock. State Street disclosed no sole voting or dispositive power; all voting authority is reported as shared over 2,846,126 shares, and all dispositive authority is reported as shared over the full 3,017,072 shares. The filing indicates ownership of 5 percent or less of the class under Item 5.

State Street identified itself as a parent holding company (type "HC") under Item 3(g). The filing lists five subsidiaries classified as investment advisers (IA) as the entities through which the securities were acquired: SSGA Funds Management, Inc.; State Street Global Advisors Europe Limited; State Street Global Advisors Limited; State Street Global Advisors Trust Company; and State Street Global Advisors, Ltd. The certification states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

State Street Corporation disclosed a 4.6% beneficial ownership position of 3,017,072 shares of Twist Bioscience Corp common stock as of September 30, 2026, held through five investment adviser subsidiaries, with all voting and dispositive power reported as shared.